# Heart-Forever

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/heart-forever

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.heart-forever.com
- Latest round: Series A (May 31, 2024)
- Investors on record: 2

## About

Established in 2020 and based in Beijing, China, Heart-Forever operates as a cardiovascular and cerebrovascular disease diagnosis and treatment service provider dedicated to providing blood pressure monitoring products. It has a sub-branch office in Tianjin. The co-founder of the company, Yibin Li graduated from Tsinghua University and has research experience in blood pressure monitoring. The co-founder of the company, Yaoguang Wei graduated from the University of Minnesota and has experience in chip design and artificial intelligence. The company has obtained 6 patents. In May 2024, it closed series A funding led by new investor Richen Capital.

The company mainly provides blood pressure monitoring equipment and blood pressure monitoring solutions through its pressure sensor, blood pressure calculation module and continuous blood pressure monitoring algorithm technology. The blood pressure monitoring equipment can be used to detect blood pressure, heart rate, blood oxygen, electrocardiogram, and sleep detection. It has functions such as non-inflated blood pressure measurement, continuous blood pressure monitoring, abnormal blood pressure reminder, etc. Heart-Forever also provides supporting application, which can provides blood pressure report. The products are mainly aimed at hypertension and cardiovascular and cerebrovascular diseases.

The company generates revenue by providing blood pressure monitoring equipment and blood pressure monitoring solutions.

The company will start mass production of the latest generation of products in June, and will use the series A funding to upgrade the underlying sensor technology, optimize the hemodynamic model algorithm, and mass produce the third-generation continuous blood pressure monitoring products.

## Funding rounds

- Series A, May 31, 2024 — Richen Capital, Frees Fund
- Angel, Feb 10, 2022 — Frees Fund

## Investors

- Frees Fund (https://capitalatlas.ai/funds/frees-fund) — Angel, Series A
- Richen Capital (https://capitalatlas.ai/funds/richen-capital) — Series A
